Volume challenges during endotoxemia | Volume challenges in controls | ||||
---|---|---|---|---|---|
Before | After | Before | After | ||
HR | All | 114 ± 15 | 113 ± 13 | 113 ± 16 | 114 ± 16 |
(beats/min) | Responders | 115 ± 16 | 110 ± 14 | 111 ± 17 | 110 ± 16 |
Nonresponders | 113 ± 12 | 115 ± 13 | 116 ± 15 | 122 ± 13 | |
MAP | All | 90 ± 30 | 98 ± 26* | 90 ± 30 | 100 ± 23* |
(mmHg) | Responders | 86 ± 31 | 99 ± 25 | 81 ± 30† | 95 ± 23 |
Nonresponders | 96 ± 28 | 96 ± 28 | 108 ± 20 | 110 ± 19 | |
CO | All | 4.3 ± 1.4 | 4.8 ± 1.3* | 5.8 ± 2.7 | 6.8 ± 2.6* |
(l/min) | Responders | 3.7 ± 1.3† | 4.6 ± 1.2 | 4.6 ± 2.4† | 5.9 ± 2.6 |
Nonresponders | 4.9 ± 1.3 | 5.0 ± 1.3 | 8.2 ± 1.5 | 8.5 ± 1.3 | |
SV | All | 38 ± 14 | 43 ± 12* | 52 ± 24 | 59 ± 21* |
(ml) | Responders | 33 ± 13† | 42 ± 12 | 42 ± 22† | 54 ± 22 |
Nonresponders | 44 ± 12 | 44 ± 12 | 71 ± 14 | 71 ± 13 | |
CVP | All | 12 ± 4 | 13 ± 4* | 7 ± 3 | 8 ± 3* |
(mmHg) | Responders | 10 ± 4‡ | 12 ± 4 | 6 ± 3† | 7 ± 3 |
Nonresponders | 13 ± 4 | 14 ± 4 | 10 ± 3 | 11 ± 2 | |
PAOP | All | 11 ± 4 | 12 ± 4* | 9 ± 4 | 10 ± 4* |
(mmHg) | Responders | 11 ± 3 | 12 ± 4 | 7 ± 3† | 9 ± 3 |
Nonresponders | 12 ± 4 | 13 ± 5 | 12 ± 3 | 13 ± 3 | |
PPV | All | 13 ± 7 | 12 ± 6 | 11 ± 8 | 9 ± 4* |
(%) | Responders | 14 ± 7 | 12 ± 5 | 14 ± 8† | 9 ± 5 |
Nonresponders | 12 ± 7 | 11 ± 6 | 7 ± 3 | 8 ± 4 |